Novavax Global Commercial Operations and COVID-19 Vaccine Update

Upcoming 2023 Milestones Receive regulatory guidance on SARS-COV-2 strain selection for 2023 fall vaccination season, including from U.S. FDA VRBPAC Updated COVID-19 vaccine supporting variant strain Topline results from Phase 2 CIC and influenza trial expected mid-year 2023 novavax > File for U.S. BLA in 2023 © 2023 NOVAVAX. All rights reserved. 23

View entire presentation